<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>RNA Editing Genes Associated Extreme Old Age Humans Lifespan C. elegans <br /> Paola Sebastiani1.*, Monty Montano2.*, Annibale Puca3, Nadia Solovieff1, Toshio Kojima4, Meng C. <br /> Wang5, Efthymia Melista6, Micah Meltzer2, Sylvia E. J. Fischer5, Stacy Andersen7, Stephen H. Hartley1, <br /> Amanda Sedgewick8, Yasumichi Arai9, Aviv Bergman10, Nir Barzilai11, Dellara F. Terry7, Alberto Riva12, <br /> Chiara Viviani Anselmi3, Alberto Malovini3, Aya Kitamoto4, Motoji Sawabe13, Tomio Arai13, Yasuyuki <br /> Gondo14, Martin H. Steinberg6, Nobuyoshi Hirose9, Gil Atzmon11, Gary Ruvkun5, Clinton T. Baldwin6&quot;, <br /> Thomas T. Perls7&quot; <br /> 1 Department Biostatistics, Boston University School Public Health, Boston, Massachusetts, United States America, 2 Department Medicine Sections Infectious <br /> Diseases, Boston University School Medicine, Boston, Massachusetts, United States America, 3 Department Genetics, IRCCS Multimedica, Milan, Italy, <br /> 4 Computational Systems Biology Research Group, Advanced Science Institute, RIKEN, Yokohama, Kanagawa, Japan, 5 Department Genetics, Massachusetts General <br /> Hospital Harvard Medical School, Boston, Massachusetts, United States America, 6 Center Human Genetics, Boston University School Medicine, Boston, <br /> Massachusetts, United States America, 7 Geriatrics Section, Department Medicine, Boston University School Medicine, Boston, Massachusetts, United States America, 8 Department Bioengineering, Boston University School Engineering, Boston, Massachusetts, United States America, 9 Division Geriatric Medicine, <br /> Department Internal Medicine, Keio University School Medicine, Tokyo, Japan, 10 Department Systems <span id='am-1' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span>amp</span>; Computational Biology, Albert Einstein College Medicine, Bronx, New York, United States America, 11 Institute Aging Research Diabetes Research Center, Departments Medicine Genetics, Albert Einstein <br /> College Medicine, Bronx, New York, United States America, 12 Department Molecular Genetics Microbiology, University Florida Gainesville, Florida, <br /> United States America, 13 Department Pathology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 14 Clinical Thanatology Geriatric Behavioral Science, <br /> Graduate School Human Sciences, Osaka University, Suita, Osaka, Japan <br />  <br />  <br />  <br />      Abstract <br />      Background: strong familiality living extreme ages suggests human longevity genetically regulated.      majority genes far associated longevity primarily function lipoprotein metabolism insulin/ <br />      IGF-1 signaling. likely genetic modifiers human longevity remain discovered. <br />  <br />      Methodology/Principal Findings:  18 single <span id='am-9' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-10' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-13' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span>nucleotide</span> polymorphisms (SNPs) RNA editing <br />      genes ADARB1 ADARB2 associated extreme old age U.S. based study centenarians, New England <br />      Centenarian Study. replications findings independently conducted centenarian studies      different genetic backgrounds (Italian, Ashkenazi Jewish Japanese) collectively support association ADARB1 <br />      ADARB2 longevity. SNPs ADARB2 replicate consistently populations suggest strong effect <br />      independent different genetic backgrounds environments. evaluate functional association      genes lifespan, demonstrate inactivation orthologues adr-1 adr-2 C. elegans reduces median <br />      survival 50%. demonstrate inactivation argonaute gene, rde-1, critical regulator RNA <br />      interference, completely restores lifespan normal levels context adr-1 adr-2 loss function. <br />  <br />      Conclusions/Significance: results suggest RNA editors important regulator aging humans       evaluated C. elegans, pathway interact RNA interference machinery regulate lifespan. <br />  <br />   Citation: Sebastiani P, Montano M, Puca  Solovieff N, Kojima T, et al. (2009) RNA Editing Genes Associated Extreme Old Age Humans Lifespan <br />   C. elegans. PLoS 4(12): e8210. doi:10.1371/journal.pone.0008210 <br />   Editor: Joanna Mary Bridger, Brunel University, United Kingdom <br />   Received July 22, 2009; Accepted November 3, 2009; Published December 14, 2009 <br />   Copyright: &#195;&#376; 2009 Sebastiani et al. open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: work supported National Institutes Health grants: R01 HL087681  M.H.S), K24 AG025727  T.T.P), R01 AR055115  M.M.), RO1 AG027216 <br />    C.B.), Italian Ministry Research University   P.  M), following grants G  B. N.B.: AG-027734, AG-18728, RR-12248, DK-20541, <br />   M01-RR12248 grant Glenn Foundation. M.C.W. supported Life Sciences Research Foundation fellowship. S.E.J.F. supported MGH <br />   ECOR Fund Medical Discovery. funders role study design, data collection analysis, decision publish, preparation manuscript. <br />   Competing Interests: authors declared competing interests exist. <br />   * E-mail: sebas@bu.edu (PS); mmontano@bu.edu (MM) <br />   . authors contributed equally work. <br />   &quot; authors contributed equally work. <br />  <br />  <br />  <br /> Introduction                                                                              broad public health significance including marked delay <br />                                                                                           age-related disability [9&#226;&#8364;&#8220;11] certain age-related diseases <br />   Exceptional longevity (EL) humans, defined living                              [12&#226;&#8364;&#8220;14]. Genetically, exceptional longevity presumed extreme old ages 100 years older, strongly familial                        complex trait [15&#226;&#8364;&#8220;19]. candidate gene association <br /> [1&#226;&#8364;&#8220;8] factors facilitate exceptional survival                           studies successful discovering longevity-associated <br />  <br />  <br />         PLoS | www.plosone.org                                                    1                             December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                           RNA Editing Oldest Age <br />  <br />  <br /> genes humans.  variants mainly                   Subjects Selected Association Study <br /> related lipoprotein metabolism [20&#226;&#8364;&#8220;22], FOXO proteins                       NECS, genotype data obtained 281 males, <br /> [23,24], insulin/IGF-1 signaling [25] likely            aged 96&#226;&#8364;&#8220;114 years 596 females, aged 100&#226;&#8364;&#8220;119 years. genetic modifiers human aging discovered             selected cutoff ages 96 years males 100 years females <br /> [25].                                                                       NECS focus extreme 1% survival based     study, investigate genes <span id='am-17' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-18' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-29' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span>adenosine</span>)        U.S. Social Security Administration cohort life table (http://www. <br /> (<span id='am-47' about='obo:IMR_0200194' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-48' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasDbXref" content="KEGG:C00294" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:id" content="IMR:0200194" datatype="xsd:string"></span><span id='am-51' property="rdfs:label" content="Inosine" datatype="xsd:string"></span>inosine</span>) RNA editing pathway, post-transcriptional process            ssa.gov/OACT/NOTES/as116/as116LOT.html). NECS refer- <span id='am-32' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-33' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-40' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-42' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span>adenosine</span> residues converted inosine resulting            ent cohort subjects consisted 270 spouses centenarian <br /> change gene expression protein function. Targets RNA               offspring children parents died mean age 73 <br /> editing include large number genes micro RNA.               years (average life expectancy parents&#226;&#8364;&#8482; birth cohort).  surprising non-specific cellular process        Additional referent subjects selected Illumina involved general maintenance cellular health           iControlDB database using genome-wide genetic matching lifespan.  implication previously              detailed methods (n = 1635). Note approximately 100 <br /> demonstrated.                                                               male centenarians included pooling-based genome screen- <br />      report significant association genes       ing overlap second set. Given overlap relatively <br /> EL centenarian studies include New England                 small (,10%) subsequent analysis uses different <br /> Centenarian Study (NECS), 1,500 individuals               analytic approach (genotype data individual subjects), primarily North European ancestry, aged 90 119               think overlap significant concern. <br /> years; Southern Italian Centenarian Study (SICS)  study               SICS, used genotype data 271 males, ages <br /> nonagenarians centenarians closed population                  90&#226;&#8364;&#8220;108 years 188 females, aged 90&#226;&#8364;&#8220;109 years (total = 459). <br /> Cilento, South Italy; Ashkenazi Jewish Centenarian Study                Data 200 male 132 female SICS referent cohort subjects <br /> (AJCS), study approximately 300 nonagenarians                      aged 18&#226;&#8364;&#8220;48 years used analysis. AJCS, <br /> centenarians founder population North Eastern                     genotype data obtained 299 oldest subjects (108 males <br /> European background, resident  Japanese               aged 95 older 191 females aged 99 older) 269 <br /> Centenarian Study (JCS), study Japanese centenarians              younger referent cohort subjects (spouses offspring focused &#226;&#8364;&#732;&#226;&#8364;&#732;semi-supercentenarians&#226;&#8364;&#8482;&#226;&#8364;&#8482; subjects living past 105          centenarians, aged 85 younger, evidence parental <br /> years [26]. characteristics populations allow         longevity). seventy oldest old subjects (82 males <br /> assess robustness associations varying genetic                aged 100&#226;&#8364;&#8220;110 years 388 females, aged 100&#226;&#8364;&#8220;116 years) background environment.                                                 538 referent cohort subjects (randomly selected Japanese subjects, <br />     evaluate functional significance RNA              aged 19&#226;&#8364;&#8220;89 years) constituted Japanese association study. <br /> editing candidate genes C. elegans lifespan studies        Table 1 reports summaries subjects&#226;&#8364;&#8482; characteristics. Ages <br /> silencing orthologs genes reduces median survival 50%.          extreme old validated birth certificates  case life span fully restored additional <br /> knockdown RNA interference gene, supporting                        Table 1. Study Subjects characteristics. <br /> functional role genes determining lifespan implicating novel axis future aging studies. <br />                                                                                              Males     Females              Males   Females Results Discussion                                                                       NECS oldest old                    NECS controls <br />                                                                              Sample Size     281       596         877          149     121         270 <br /> Selection Candidate Genes <br />    selected genes study multiple reasons.         Median Age      102       103         103          75      74          75 preliminary genome wide screening using pooled DNA samples                 Age Range       96&#226;&#8364;&#8220;114    100&#226;&#8364;&#8220;119     96&#226;&#8364;&#8220;119       58&#226;&#8364;&#8220;85   53&#226;&#8364;&#8220;85       53&#226;&#8364;&#8220;85 approximately 130 male centenarians 130 younger male                                SICS oldest old                    SICS controls <br /> controls NECS [27], identified single                    Sample Size     271       188         459          200     132         332 <br /> nucleotide polymorphisms (SNPs) RNA-editing genes                     Median Age      94        98          96           34      32          33 <br /> ADARB1 (21q22.3), ADARB2 (10p15.3) associated <br />                                                                              Age Range       90&#226;&#8364;&#8220;109    90&#226;&#8364;&#8220;109      90&#226;&#8364;&#8220;109       18&#226;&#8364;&#8220;48   18&#226;&#8364;&#8220;48       18&#226;&#8364;&#8220;48 extreme old age. ADARB1 exhibited strongest evidence genetic association 5 SNPs met genome-wide                                     NA                                 Illumina controls <br /> significance, posterior odds allelic association .1,500          Sample Size                                        418     1217        1635 <br /> [27]. probability 5 SNPs simultaneously associated              Median Age                                         47      46          47 null hypothesis association 10213 based             Age Range                                          30&#226;&#8364;&#8220;75   30&#226;&#8364;&#8220;75       30&#226;&#8364;&#8220;75 hyper-geometric distribution. Second, gene lies chromo-                            AJCS oldest old                    AJCS controls 21q21 trisomy 21  syndrome) resembles <br />                                                                              Sample Size     108       191         299          118     151         269 <br /> accelerated aging, premature age-related changes including skin hair, increased frequency premature cataracts,            Median Age      99        101         100          77      73          73 <br /> hearing loss, menopause Alzheimer&#226;&#8364;&#8482;s disease [28] suggesting              Age Range       95&#226;&#8364;&#8220;108    99&#226;&#8364;&#8220;112      95&#226;&#8364;&#8220;112       54&#226;&#8364;&#8220;85   46&#226;&#8364;&#8220;85       46&#226;&#8364;&#8220;85 genes chromosome 21 affect lifespan.                               JCS oldest old                     JCS controls genes identified preliminary genetic screen, RNA            Sample Size     82        388         470          178     360         538 <br /> editing represents general cellular process expected         Median Age      104       106         106          21      72          69 improve cellular health; RNA editing activity                                                                              Age Range       100&#226;&#8364;&#8220;111 100&#226;&#8364;&#8220;116       100&#226;&#8364;&#8220;116      19&#226;&#8364;&#8220;89   19&#226;&#8364;&#8220;89       19&#226;&#8364;&#8220;89 <br /> associated innate immune response [29,30] age-related <br /> syndromes include dementia amyotrophic lateral sclerosis            Reported summaries contact ages. <br /> (ALS) [31].                                                                  doi:10.1371/journal.pone.0008210.t001 <br />  <br />  <br />  <br />       PLoS | www.plosone.org                                        2                          December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                                       RNA Editing Oldest Age <br />  <br />  JCS, Basic Resident Registration Card). subjects                      errors suggesting real associations enrolled studies Institutional Review Board approval                    artifacts. oversight.                                                                          test generalizability results                                                                                      independent groups, evaluated associations Association ADARB1 Exceptional Longevity                                     AJCS JCS, using combination proxy SNPs typed <br />    examined associations 31 SNPs ADARB1                          Affymetrix platforms SNPs Table 3 typed NECS SICS samples using recessive dominant models                            traditional techniques  methods). Table 4 summa- Bayesian logistic regression [32]. details statistical               rizes results replication study 4 5 SNPs analysis Methods significant results                          additional proxy SNP Table 5. SNPs summarized Table 2 provides physical positions                       ADARB1 replicates results NECS SICS samples <br /> allele frequencies derived HapMap SNPs,                       significant association SNP rs17004734 <br /> Table 3 (rows 14&#226;&#8364;&#8220;15). SNPs ADARB1 strongly                               2Kb rs414743 consistent associated extreme old age NECS, association                     presence longevity associated variants region. SNP rs414743 remains significant imposing                              SNPs used NECS SICS chosen best <br /> stringent corrections multiple comparisons (Bayesian signif-                     capture genetic variations Caucasians icance ,0.05/145 = 0.00035 145 overall number                        HapMap, correct choice founder <br /> SNPs included analysis). SNPs tag region                     population Figure 1 shows different pattern strong linkage disequilibrium (LD) gene (Figure 1).                   LD ADARB1 AJCS subjects. ADARB1 SNPs SNPs reached statistical significance SICS                   Table 3 additional proxy SNPs genotyped SNPs rs2838809, rs2838810 rs2838816 exhibited                              JCS subjects Tables 6 7 summarize results. consistent associations terms odds ratios allele                           SNPs Table 6 effects consistent frequencies  NECS SICS data combined,                          NECS SICS subjects reach statistical SNPs remained statistically significant.                       significance, data studies SNPs extreme minor allele frequencies NECS                               aggregated. Figure 3 shows posterior densities ORs <br /> centenarians (MAF,0.01), allele frequencies                         rare SNPs suggestive association controls close referent allele frequencies                      need larger sample sizes reach statistical <br /> HapMap (Table 3). Figure 2 displays scatter plot genotype                     significance. association proxy SNPs rs2838816 <br /> intensities generated BeadStudio rules genotyping                      Table 7 consistent presence longevity <br />  <br />  <br />  <br />  <br />  Table 2. Summary selected SNPs. <br />  <br />  <br />                                                                                                         Risk versus <br />  Row                  SNP                              Chr                  position                    referent alleles                 CEPH                  JPT <br />  <br />  1                    rs10903420                       10                   1333726                     AA v AG/GG                       0.327                 0.058 <br />  2                    rs1007147                        10                   1341088                     AA v AG/GG                       0.312                 0.091 <br />  3                    rs2805562                        10                   1357514                     AA v AG/GG                       0.15                  0.058 <br />  4                    rs884949                         10                   1361610                     AA v AC/CC                       0.124                 0 <br />  5                    rs2805533                        10                   1374633                     AA/AG v GG                       0.77                  0.92 <br />  6                    rs2387653                        10                   1397826                     AA v AG/GG                       0.097                 0 <br />  7                    rs2805535                        10                   1450432                     AA v AG/GG                       0.699                 0.151 <br />  8                    rs2805543                        10                   1454892                     AA v AG/GG                       0.46                  0.105 <br />  9                    rs3898610                        10                   1474759                     AA v AG/GG                       0.841                 0.686 <br />  10                   rs1533484                        10                   1481339                     AA/AG v GG                       0.442                 0.791 <br />  11                   rs2676192                        10                   1495474                     AA v AG/GG                       0.301                 0.419 <br />  12                   rs2387952                        10                   1657365                     AA v AG/GG                       0.69                  0.616 <br />  13                   rs17294019                       10                   1659347                     AA/AG v GG                       0.196                 0.012 <br />  14                   rs3788157                        21                   45335136                    AA v AG/GG                       0.63                  0.65 <br />  15                   rs414743                         21                   45336503                    AA/AG v GG                       0.47                  0.31 <br />  16                   rs2838809                        21                   45445866                    AA v AG/GG                       0.009                 0 <br />  17                   rs2838810                        21                   45447751                    AA/AG v GG                       1                     1 <br />  18                   rs2838816                        21                   45454470                    AA v AG/GG                       0.009                 0 <br />  <br />  List 18 SNPs &#226;&#8364;&#8221;13 gene ADARB2 (10p15.3) 5 gene ADARB1 (21q22.3) &#226;&#8364;&#8221; associated exceptional longevity dominant  recessive models. table reports sequential number easy identification tables figures (column 1), SNP identifier dbSNP (column 2), <br />  chromosome physical position human genome NCBI Build 36.3 (columns 3 4), risk versus referent alleles associated exceptional <br />  longevity using dominant recessive models (column 5), frequencies risk allele HapMap CEPH JPT. Note alleles Japanese <br />  group allele frequencies change substantially CEPH, SNPs rows 4 6 monomorphic. <br />  doi:10.1371/journal.pone.0008210.t002 <br />  <br />  <br />  <br />        PLoS | www.plosone.org                                                3                            December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                Table 3. SNPs ADARB2 (10p15.3) ADARB1 (21q22.3) associated exceptional longevity NECS SICS subjects. <br />  <br />  <br />                                                                                         Risk versus <br />                                                             Row      SNP                referent alleles        CEPH       NECS (877 oldest old, 1808 controls)                   SICS (459 oldest old, 429 controls)                 NECS+SICS <br />  <br />  <br />  <br />  <br /> PLoS | www.plosone.org <br />                                                                                                                                                 Bayes sig     p                                Bayes sig     p                                  Bayes sig        p  <br />  <br />                                               ADARB2        1        rs10903420         AA v AG/GG              0.327      1.28(1.07;1.53)         0.0048        0.28/0.23        1.14(0.84;1.54)      0.1212        0.28/0.25        1.25(1.07;1.45)        0.0020           0.28/0.24 <br />                                                             2        rs1007147          AA v AG/GG              0.312      1.35(1.13;1.64)         0.0015        0.27/0.22        1.25(0.92;1.66)      0.2040        0.29/0.25        1.34(1.15;1.59)        0.0003           0.27/0.22 <br />                                                             3        rs2805562          AA v AG/GG              0.15       1.22(0.96;1.54)         0.0500        0.15/0.12        1.38(0.97;1.97)      0.0384        0.20/0.15        1.32(1.09;1.59)        0.0022           0.16/0.13 <br />                                                             4        rs884949           AA v AC/CC              0.124      1.19(0.92;1.53)         0.0911        0.12/0.10        1.31(0.87;1.96)      0.0978        0.14/0.11        1.24(1.01;1.54)        0.0211           0.12/0.10 <br />                                                             5        rs2805533          AA/AG v GG              0.77       0.91(0.75;1.12)         0.1904        0.78/0.81        0.83(0.60;1.14)      0.1217        0.76/0.79        0.86(0.72;1.02)        0.0381           0.79/0.81 <br />                                                             6        rs2387653          AA v AG/GG              0.097      1.17(0.91;1.50)         0.1053        0.14/0.12        1.12(0.78;1.62)      0.2699        0.170.16         1.21(0.99;1.49)        0.0343           0.15/0.13 <br />                                                             7        rs2805535          AA v AG/GG              0.699      1.36(1.02;1.83)         0.0249        0.75/0.69        1.31(0.97;1.79)      0.0395        0.72/0.66        1.37(1.11;1.68)        0.0017           0.74/0.68 <br />                                                             8        rs2805543          AA v AG/GG              0.46       1.23(1.04;1.45)         0.0055        0.54/0.49        1.36(1.03;1.76)      0.0156        0.51/0.43        1.24(1.08;1.42)        0.0008           0.53/0.48 <br />  <br />  <br />  <br />  <br /> 4 <br />                                                             9        rs3898610          AA v AG/GG              0.841      1.42(1.11;1.77)         0.0015        0.88/0.83        1.19(0.80;1.74)      0.1973        0.87/0.85        1.36(1.12;1.67)        0.0015           0.87/0.84 <br />                                                             10       rs1533484          AA/AG v GG              0.442      0.81(0.70;0.97)         0.0109        0.35/0.40        0.79(0.63;1.01)      0.0428        0.43/0.49        0.86(0.75;0.98)        0.0147           0.38/0.42 <br />                                                             11       rs2676192          AA v AG/GG              0.301      0.81(0.67;0.98)         0.0096        0.26/0.30        0.95(0.74;1.31)      0.3869        0.26/0.27        0.83(0.71;0.96)        0.0086           0.26/0.30 <br />                                                             12       rs2387952          AA v AG/GG              0.69       1.37(1.15;1.66)         0.0004        0.75/0.69        1.05(0.80;1.37)      0.3484        0.66/0.65        1.20(1.04;1.40)        0.0073           0.72/0.68 <br />                                                             13       rs17294019         AA/AG v GG              0.196      0.69(0.55;0.86)         0.0005        0.14/0.19        0.80(0.59;1.10)      0.0826        0.22/0.27        0.78(0.65;0.93)        0.0030           0.17/0.21 <br />                                               ADARB1        14       rs3788157          AA v AG/GG              0.63       1.23(1.05;1.45)         0.0075        0.65/0.62        0.90(0.68;1.19)      0.2318        0.65/0.67        1.16(1.00;1.34)        0.0204           0.65/0.62 <br />                                                             15       rs414743           AA/AG v GG              0.47       0.72(0.61;0.85)         ,1025         0.40/0.48        1.08(0.83;1.45)      0.2689        0.49/0.46        0.83(0.72;0.96)        0.0053           0.43/0.48 <br />                                                             16       rs2838809          AA v AG/GG              0.009      0.27(0.05;0.93)         0.0096        0.003/0.009      0.58(0.15;1.97)      0.1973        0.011/0.016      0.46(0.19;1.08)        0.0297           0.005/0.01 <br />                                                             17       rs2838810          AA/AG v GG              1          3.71(1.12;19.29)        0.0136        0.997/0.990      2.29(0.63;10.33)     0.1088        0.991/0.984      2.73(1.11;8.25)        0.0136           0.995/0.99 <br />                                                             18       rs2838816          AA v AG/GG              0.009      0.28(0.05;0.93)         0.0116        0.003/0.009      0.58(0.15;1.98)      0.1934        0.011/0.016      0.48(0.18;1.04)        0.0309           0.005/0.01 <br />  <br />                                               13 SNPs gene ADARB2 (10p15.3) SNPs gene ADARB1 (21q22.3). Columns 1&#226;&#8364;&#8220;4 provide details SNPs table 2. Columns 5&#226;&#8364;&#8220;7 report results association NECS                                               referent subjects based Bayesian logistic regression dominant recessive models. Specifically, column 5 reports Bayesian estimate odds ratio 95% credible interval brackets, columns 6 reports                                               Bayes significance defined 1-p 1) posterior estimate .1 1-p 1) posterior estimate ,1. number posterior probability null hypothesis 1                                               estimate 1  OR$1 estimate 1) small values provide strong evidence null hypothesis similar Bayes p-value proposed Althman. Column 7 reports posterior probability                                               risk allele cases controls. Highlighted bold significant associations (Bayes significance ,0.05). Columns 8&#226;&#8364;&#8220;10 report replications SICS highlighted bold 4 SNPs significant                                               analysis. Columns 11&#226;&#8364;&#8220;12 report results analysis data studies aggregated. 15 SNPs reach statistical significance NECS 4 SNPs SICS, 18 consistent <br />                                               effects data studies aggregated, SNPs remain significant significance 11 stronger. <br />                                               doi:10.1371/journal.pone.0008210.t003 <br />  <br />  <br />  <br />  <br /> December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                                                                                                                                                                                              RNA Editing Oldest Age <br />                                                                                                                     RNA Editing Oldest Age <br />  <br />  <br />  <br />  <br /> Figure 1. Pattern LD SNP ADARB1 (chromosome 21) associated exceptional longevity. plots <br /> display pattern LD captured SNPs associated exceptional longevity ADARB1 (chromosome 21) using data NECS, SICS, <br /> AJCS JCS. intensity red represents strength LD measured D9. <br /> doi:10.1371/journal.pone.0008210.g001 <br />  <br />  <br /> associated variants gene captured              exhibit consistent associations terms odds ratios allele SNP selection Japanese population.                             frequencies combining data NECS SICS                                                                           associations stronger plus additional Association ADARB2 Exceptional Longevity                          SNPs statistically significant. SNPs tag region    examined associations 114 SNPs ADARB2              approximately 160Kb ADARB2 includes blocks LD <br /> NECS SICS samples using recessive dominant               (Figure 4). <br /> models. SNPs strongly associated extreme old age               Tables 4 5 summarize results replication 10 NECS, remains significant correcting        SNPs AJCS subjects. SNPs reach statistical <br /> multiple comparisons (SNPs rs2387952, Bayesian significance               significance set (rows 3 13) opposite effects <br /> 0.0004,0.05/145). significant SNPs (rs2805562;              compared NECS SICS (rows 13).  SNPs rs2805533; rs2805543; rs1533484) replicated          rows 1, 5&#226;&#8364;&#8220;9, 11 12 effects consistent SICS (Bayes significance ,0.05) (Table 3). remaining              NECS SICS  data 3 studies SNPs did reach statistical significance SICS did           aggregated, significant (columns 12&#226;&#8364;&#8220;14). SNPs  <br />  <br />       PLoS | www.plosone.org                                      5                        December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                        RNA Editing Oldest Age <br />  <br />  <br />  <br />  <br /> Figure 2. Result genotype cluster algorithm BeadStudio. plots normalized intensities polar coordinate cluster <span id='am-8' about='obo:IAO_0000115' typeof='owl:Thing'>definition</span> BeadStudio NECS subjects. clear separation suggests genotype calls robust. <br /> doi:10.1371/journal.pone.0008210.g002 <br />  <br /> rows 2, 4, 11 typed proxy SNPs typed              elegans [31,35]. lifespan analysis, focused C. elegans, <br /> Affymetrix 6.0 array confirm strong associations variants         orthologues ADARB1 ADARB2 RNA region EL. SNPs summarized Table 5               editing activity, adr-1 adr-2 [36]  phylogenetic tree good proxy SNPs originally typed NECS              Figure S1). C. elegans average lifespan SICS shown proximity terms physical distance              approximately 20 days, influence candidate genes ,10kb linkage disequilibrium measured D9 r2.                     lifespan readily tested.  evaluate adr <br />    SNP rs2805533 reached statistical significance JCS           loss function influences C. elegans lifespan, monitored set, effect consistent observed effect         lifespan single double mutants adr-1(gv6) adr-2(gv42). NECS, SICS AJCS samples (Table 6). SNP                          alleles deletions remove rs1533484 borderline significant (Bayesian significance                 coding sequence presumed null alleles [36] (Figure 6a ,0.06) demonstrates consistent effects NECS                Figure S2). Strains carrying mutations adr-1 adr-2 displayed <br /> SICS results, allele frequencies substantially different.       shorter lifespan wild-type control N2 worms (log-rank SNP rs10903420 significant opposite                test p,1028). Remarkably, aside decline lifespan, <br /> effect compared NECS, SICS AJCS subject sets. Note               obvious defects, contrast gain  substantial differences allele frequencies          function studies noted lethality Drosophila [37]. <br /> pattern LD explain different patterns                        insulin-like growth factor (IGF) pathway known <br /> associations ethnically distinct sample. Genotype data         lifespan regulatory axis worms [38], flies [39,40], mice [41], additional SNPs Table 7 provide evidence              humans [42]. Inactivation C. elegans insulin like receptor <br /> existence variants region physical positions              gene daf-2 dsRNA increased lifespan wild type N2 <br /> 1340K 1500K chromosome 10 associated                   worms, confirming previous studies. Notably, knockdown daf-2 <br /> exceptional longevity.                                                      dsRNA increased lifespan background adr-1                                                                             adr-2 null mutations, resulting lifespan phenocopy similar                                                                             wild type N2 worms (Figure 6a). Similar extensions lifespan <br /> Age Trends <br />                                                                             seen single adr-1 adr-2 mutants, (Figure S2).    SNPs, clear monotonic pattern associated                                                                             data suggest IGF axis mediated increases lifespan increasing age observed (Figure 5). monotonic pattern                                                                             daf-2 remain active presence adr-1 adr-2 background <br /> consistent genetic effect results alleles positively       genotypes, potency N2 wild type <br /> associated EL frequent older individuals,             background. data, exclude possibility alleles negatively associated EL            knockdown RNA editing genes adr-1 adr-2 mutants <br /> frequent. pattern observed ApoE alleles [33]         results increased RNAi activity. scenario, increased consistent phenomenon demographic selection              RNAi target genes downstream daf-16 (seven daf-16 gene <br /> [34]. increases allele frequencies age illustrate        targets identified comparative analysis daf-2 versus increasing gain power conferred studying centenarians             daf-2::daf-16 strains [43]), reducing potency daf-2  subjects age 105+ years, genetic studies            dependent increases lifespan. <br /> exceptional survival.                                                           previous study, mutations adr-1 adr-2 resulted                                                                             increased GFP reporter transgene silencing, suggesting Functional Studies                                                          declines ADAR function associated increase    statistical association, chose investigate        RNA interference (RNAi), account GFP <br /> possible functional role genes regulating lifespan           silencing experiments. argonaute gene rde-1, <br /> evaluating influence lifespan nematode, C. elegans,       essential RNA induced silencing complex (RISC) <br /> robust model organism candidate lifespan gene discovery.            formation, introduced adr-1;adr-2 worms containing RNA editing gene family enzymatic editing                  transgenes, increased GFP silencing ADAR knockdown <br /> activity conserved broad array species                suppressed [44]. suggests cross-regulation RNA <br /> including humans, mice, flies, zebrafish, xenopus notably, C.           editors RNA interference supported results <br />  <br />  <br />       PLoS | www.plosone.org                                        6                        December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                Table 4. Replication AJCS subject set. <br />  <br />  <br />                                                                                           Risk versus <br />                                                            Row         SNP                referent alleles       CEPH       NECS+SICS                                             AJCS (299 oldest old, 269 controls)                NECS+SICS+AJCS <br />  <br />  <br />  <br />  <br /> PLoS | www.plosone.org <br />                                                                                                                                                  Bayes sig       p                             Bayes sig     p                                 Bayes sig       p  <br />  <br />                                               ADARB2       1           rs10903420         AA v AG/GG             0.327      1.25(1.07;1.45)         0.0020          0.28/0.24     1.37(0.87;2.18)      0.0861        0.27/0.21       1.26(1.09;1.45)        0.0010          0.28/0.24 <br />                                                            2           rs1007147          AA v AG/GG             0.312      1.34(1.15;1.59)         0.0003          0.27/0.22 <br />                                                            3           rs2805562          AA v AG/GG             0.15       1.32(1.09;1.59)         0.0022          0.16/0.13     1.88(1.10;3.22)      0.0095        0.21/0.17       1.39(1.16;1.65)        ,1025           0.17/0.13 <br />                                                            4           rs884949           AA v AC/CC             0.124      1.24(1.01;1.54)         0.0211          0.12/0.10 <br />                                                            5           rs2805533          AA/AG v GG             0.77       0.86(0.72;1.02)         0.0381          0.79/0.81     0.73(0.45;1.18)      0.0955        0.76/0.81       0.84(0.72;0.98)        0.0129          0.78/0.81 <br />                                                            6           rs2387653          AA v AG/GG             0.097      1.21(0.99;1.49)         0.0343          0.15/0.13     1.40(0.83;2.38)      0.1030        0.20/0.15       1.27(1.05;1.53)        0.0082          0.17/0.13 <br />                                                            7           rs2805535          AA v AG/GG             0.699      1.37(1.11;1.68)         0.0017          0.74/0.68     1.27(0.82;1.95)      0.1476        0.81/0.77       1.28(1.06;1.54)        0.0050          0.73/0.70 <br />                                                            8           rs2805543          AA v AG/GG             0.46       1.24(1.08;1.42)         0.0008          0.53/0.48     1.26(0.85;1.87)      0.1217        0.51/0.45       1.22(1.08;1.39)        0.0001          0.52/0.47 <br />  <br />  <br />  <br />  <br /> 7 <br />                                                            9           rs3898610          AA v AG/GG             0.841      1.36(1.12;1.67)         0.0015          0.87/0.84     0.63(0.35;1.16)      0.0685        0.87/0.91       1.29(1.07;1.55)        0.0035          0.87/0.84 <br />                                                            10          rs1533484          AA/AG v GG             0.442      0.86(0.75;0.98)         0.0147          0.38/0.42 <br />                                                            11          rs2676192          AA v AG/GG             0.301      0.83(0.71;0.96)         0.0086          0.26/0.30     0.77(0.52;1.15)      0.0986        0.27/0.32       0.83(0.72;0.95)        0.0037          0.26/0.30 <br />                                                            12          rs2387952          AA v AG/GG             0.69       1.20(1.04;1.40)         0.0073          0.72/0.68     0.95(0.61;1.44)      0.3977        0.67/0.69       1.17(1.01;1.34)        0.0146          0.71/0.68 <br />                                                            13          rs17294019         AA/AG v GG             0.196      0.78(0.65;0.93)         0.0030          0.17/0.21     1.42(0.95;2.13)      0.0451        0.31/0.24 <br />                                               ADARB1       14          rs3788157          AA v AG/GG             0.63       1.16(1.00;1.34)         0.0204          0.65/0.62     0.73(0.50;1.05)      0.0463        0.58/0.65 <br />                                                            15          rs414743           AA/AG v GG             0.47       0.83(0.72;0.96)         0.0053          0.43/0.48 <br />                                                            16          rs2838809          AA v AG/GG             0.009      0.46(0.19;1.08)         0.0297          0.005/0.01    1.19(0.44;3.29)      0.3662        0.040/0.034 <br />                                                            17          rs2838810          AA/AG v GG             1          2.73(1.11;8.25)         0.0136          0.995/0.99    0.99(0.39;2.53)      0.4951        0.956/0.956 <br />                                                            18          rs2838816          AA v AG/GG             0.009      0.48(0.18;1.04)         0.0309          0.005/0.01    1.06(0.38;3.06)      0.4573        0.035/0.034 <br />  <br />                                               List SNPs ADARB2 ADARB1 reach statistical significance NECS SICS attempted replicated AJCS set. 7 columns report details SNPs described legend                                               Table 3. Columns 8&#226;&#8364;&#8220;11 report results 14 18 SNPs Table 3 genotyped 255 oldest old 227 younger controls AJCS. 3 SNPs reach statistical significance set (rows 3, 13 14)                                               opposite effects compared NECS SICS (rows 13 14).  SNPs rows 1, 5&#226;&#8364;&#8220;9, 11 12 effects consistent NECS SICS  data 3 studies aggregated, <br />                                               significant (columns 12&#226;&#8364;&#8220;14). SNPs rows 2, 4, 10 11 typed proxy SNPs ongoing genome wide association study conducted Affymetrix 6.0 array suggest strong associations <br />                                               region. <br />                                               doi:10.1371/journal.pone.0008210.t004 <br />  <br />  <br />  <br />  <br /> December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                                                                                                                                                                                          RNA Editing Oldest Age <br />                                                                                                                                                                                                                                                                                                                                                                                                                                                                         RNA Editing Oldest Age <br />  <br />  <br />  <br />  <br />                                                                           referent allele <br />                                                                                                                                                                                                                                                                                                                                                                                                                               Tonkin et al [45], demonstrated mild <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                 Additional proxy SNPs genotyped AJCS set tag region shown proximity terms physical distance ,10kb linkage disequilibrium measured D9 r2  Figure 1). <br />                                                                           Risk versus <br />  <br />  <br />  <br />  <br />                                                                                                                                                                               AA/AG v GG <br />                                                                                                                                           AA v TT <br />                                                                                                                                                             CC v CT/TT <br />                                                                                                                                                                                                                                                                                                                                                                                                                               chemotaxis defect adr-1;adr-2 double mutant                                                                                                                                                                                                                                                                                                                                                                                                                               rescued rde-1 mutant [45].  evaluate                                                                                                                                                                                                                                                                                                                                                                                                                               potential cross-regulation RNA editing RNA <br />                                                                                                                                                                                                                                                                                                                                                                                                                               interference context lifespan, evaluated adr-1; adr-2 <br />                                                                                                                                                                                                                                                                                                                                                                                                                               mediated declines lifespan presence RNAi defective <br />  <br />  <br />  <br />  <br />                                                                                                                                           0.76/0.85 <br />                                                                                                                                                             0.23/0.16 <br />                                                                                                                                                                               0.95/0.98 <br />                                                                                                                                                                                                                                                                                                                                                                                                                               strain, rde-1(ne-219). Remarkably, consistent previous <br />  <br />  <br />                                                                                    AJCS (255 oldest old, 227 controls) <br />  <br />                                                                                                                            p  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               results, loss rde-1 completely restored lifespan declines <br />                                                                                                                                                                                                                                                                                                                                                                                                                               associated adr-1; adr-2 loss function (Figure 6b).  <br />                                                                                                                            Bayes sig <br />                                                                                                                                                                                                                                                                                                                                                                                                                               interpret data expanding interaction  <br />  <br />  <br />                                                                                                                                                             0.0269 <br />                                                                                                                                                                               0.0259 <br />                                                                                                                                                                                                                                                                                                                                                                                                                               RNA regulatory pathways include lifespan determination. <br />                                                                                                                                           0.01 <br />                                                                                                                                                                                                                                                                                                                                                                                                                                  experiments C. elegans raise question                                                                                                                                           0.56(0.33;0.91) <br />                                                                                                                                                                                                                                                                                                                                                                                                                               precise role RNA editing gene activity human aging, <br />                                                                                                                                                             1.62(1.00;2.73) <br />                                                                                                                                                                               0.29(0.06;1.00) <br />                                                                                                                                                                                                                                                                                                                                                                                                                               remains unknown.  demonstration                                                                                                                                                                                                                                                                                                                                                                                                                               family genes implicated regulation aging                                                                                                                                                                                                                                                                                                                                                                                                                               organisms warrants validation species, particularly <br />                                                                                                                                                                                                                                                                                                                                                                                                                               humans, provides novel regulatory axis future studies <br />                                                                                                                             <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               regulatory pathways influence aging process.                                                                                                                                                                                                                                                                                                                                                                                                                               speculate unidentified ADAR variants delay age <br />                                                                                                                                                             1.00/0.58 <br />                                                                                                                                                                               1.00/0.07 <br />                                                                                                                                           0.63/0.3 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               associated declines ADAR activity. note reduction                                                                                                                          Distance D9/r2 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               ADAR enzymatic activity associated Dementia, ALS                                                                                                                                                                                                                                                                                                                                                                                                                               Alzheimers disease normal aging individuals [46]. Consistent <br />                                                                                                                                                                                                                                                                                                                                                                                                                               interpretation, analysis published transcriptional <br />                                                                                                                                           11041 <br />                                                                                                                                                             2224 <br />                                                                                                                                                                               2383 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               profiles aging C. elegans indicate adr-1 adr-2 <br />                                                                                                                                                                                                                                                                                                                                                                                                                               expression peak early adulthood decline age                                                                                                                                                                                                                                                                                                                                                                                                                               precipitously. declines observed study compatible <br />                                                                                                                                                                               45345886 <br />                                                                                                                                           1352129 <br />                                                                                                                                                             1361386 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               protective role ADAR alleles aging. <br />                                                                                                                            Position <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                                  Prior study, RNA editing directly <br />                                                                                                                                                                                                                                                                                                                                                                                                                               implicated regulation aging humans C. elegans. <br />                                                                                                                                                                                                                                                                                                                                                                                                                               impact lifespan observed C. elegans <br />                                                                                                                                                                                                                                                                                                                                                                                                                               appears independent insulin signaling (Figure 6a),                                                                                                                                                             rs10903426 <br />                                                                                                                                                                               rs17004734 <br />                                                                                    Proxy SNPs <br />  <br />  <br />  <br />                                                                                                                                           rs2804097 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               interaction RNA editing RNA interference likely                                                                                                                                                                                                                                                                                                                                                                                                                               complex decreased insulin signaling C. elegans                                                                                                                            SNP <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               affect RNA interference [47] suggest threshold effects <br />                                                                                                                                                                                                                                                                                                                                                                                                                               associated declining levels insulin signaling. Future studies <br />                                                                                                                                                                                                                                                                                                                                                                                                                               needed identify characterize targets RNA editing <br />                                                                                                                                           0.27/0.22 <br />                                                                                                                                                             0.12/0.10 <br />                                                                                                                                                                               0.43/0.48 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               potential role(s) modulating RNA interference activity, <br />                                                                                                                            p  <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               context aging age-related diseases. <br />                                                                                                                                                                                                                                                                                                                                                                                                                                  analysis provides strong evidence association                                                                                                                            Bayes sig <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               ADARB1 ADARB2 extreme old age. findings                                                                                                                                           0.0003 <br />                                                                                                                                                             0.0211 <br />                                                                                                                                                                               0.0053 <br />          Table 5. Replication AJCS subject set using proxy SNPs. <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               strongest association NECS sample consistent                                                                                                                                                                                                                                                                                                                                                                                                                               sample largest oldest studies.                                                                                                                                                                                                                                                                                                                                                                                                                               lack reproducibility SNPs                                                                                                                                                                                                                                                                                                                                                                                                                               differences overall genetic background (ethnicity), size                                                                                                                                           1.34(1.15;1.59) <br />                                                                                                                                                             1.24(1.01;1.54) <br />                                                                                                                                                                               0.83(0.72;0.96) <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               younger ages oldest old samples. Nonetheless, associations <br />                                                                                    NECS+SICS <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               noted different study populations suggesting                                                                                                                                                                                                                                                                                                                                                                                                                               associations ADARB1 ADARB2 EL robust <br />                                                                                                                             <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               different genetic backgrounds environmental exposures. <br />                                                                                                                                                                                                                                                                                                                                                                                                                               ADARB2 large gene spanning 500Kb                                                                                    CEPH <br />  <br />  <br />  <br />                                                                                                                                           0.312 <br />                                                                                                                                                             0.124 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               chromosome 10, analysis narrows association                                                                                                                                                                               0.47 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               region approximately 100Kb followed fine <br />                                                                                                                                                                                                                                                                                                                                                                                                                               mapping sequencing discovering functional variants                                                                           referent alleles <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               provide better understanding function genes                                                                                                                                                                                                 doi:10.1371/journal.pone.0008210.t005 <br />                                                                           Risk versus <br />  <br />  <br />  <br />  <br />                                                                                                                                                                               AA/AG v GG <br />                                                                                                                                           AA v AG/GG <br />                                                                                                                                                             AA v AC/CC <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               human aging. <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               Materials Methods <br />                                                                                                                                                                                                                                                                                                                                                                                                                               Ethic Statement <br />                                                                                                                                           rs1007147 <br />                                                                                                                                                             rs884949 <br />                                                                                                                                                                               rs414743 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                                 Subjects included NECS, SICS, AJCS JCS provided <br />                                                                                                                                                                                                                                                                                                                                                                                                                               written informed consent, research involving human <br />                                                                                    SNP <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               subjects approved Institutional Review Boards                                                                                                                                                                                                                                                                                                                                                                                                                               Boston University, Boston, USA (NECS), &#226;&#8364;&#732;&#226;&#8364;&#732;Istituto di Ricovero <br />                                                                                    Row <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               e Cura Carattere Scientifico &#226;&#8364;&#732;&#226;&#8364;&#732;Multimedica, Milano, Italy (SICS), <br />                                                                                                                                                                               15 <br />                                                                                                                                           2 <br />                                                                                                                                                             4 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                                                                               Albert Eistein College Medicine, Bronx, USA (AJCS), Keio <br />  <br />  <br /> PLoS | www.plosone.org                                                                                                                                                                                                                                                                                                                                                                                                8                        December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                                          RNA Editing Oldest Age <br />  <br />  <br />  <br />  Table 6. Replication JCS subject set. <br />  <br />  <br />                                        Risk versus <br />               Row     SNP              referent alleles      CEPH      NECS+SICS                                      JPT     JCS (470 oldest old, 538 controls) <br />  <br />                                                                                           Bayes sig p                                    Bayes sig p  <br />  <br />  ADARB2       1       rs10903420       AA v AG/GG            0.327     1.25(1.07;1.45)       0.0020      0.28/0.24    0.058   0.51(0.23;1.07) 0.0397         0.03/0.045 <br />               2       rs1007147        AA v AG/GG            0.312     1.34(1.15;1.59)       0.0003      0.27/0.22    0.091   1.10(0.68;1.81)    0.3435      0.08/0.075 <br />               3       rs2805562        AA v AG/GG            0.15      1.32(1.09;1.59)       0.0022      0.16/0.13    0.058   0.67(0.26;1.56)    0.1813      0.02/0.03 <br />               4       rs884949         AA v AC/CC            0.124     1.24(1.01;1.54)       0.0211      0.12/0.10    0 <br />               5       rs2805533        AA/AG v GG            0.77      0.86(0.72;1.02)       0.0381      0.79/0.81    0.92    0.59(0.37;0.92) 0.0110         0.88/0.93 <br />               6       rs2387653        AA v AG/GG            0.097     1.21(0.99;1.49)       0.0343      0.15/0.13    0 <br />               7       rs2805535        AA v AG/GG            0.699     1.37(1.11;1.68)       0.0017      0.74/0.68    0.151   1.02(0.69;1.49)    0.4690      0.14/0.14 <br />               8       rs2805543        AA v AG/GG            0.46      1.24(1.08;1.42)       0.0008      0.53/0.48    0.105   0.86(0.57;1.30)    0.2381      0.10/0.12 <br />               9       rs3898610        AA v AG/GG            0.841     1.36(1.12;1.67)       0.0015      0.87/0.84    0.686   1.09(0.83;1.43)    0.2619      0.66/0.64 <br />               10      rs1533484        AA/AG v GG            0.442     0.86(0.75;0.98)       0.0147      0.38/0.42    0.791   0.79(0.58;1.07) 0.0641         0.76/0.80 <br />               11      rs2676192        AA v AG/GG            0.301     0.83(0.71;0.96)       0.0086      0.26/0.30    0.419   0.92(0.71;1.19)    0.2542      0.40/0.42 <br />               12      rs2387952        AA v AG/GG            0.69      1.20(1.04;1.40)       0.0073      0.72/0.68    0.616   0.98(0.76;1.28)    0.4576      0.59/0.60 <br />               13      rs17294019       AA/AG v GG            0.196     0.78(0.65;0.93)       0.0030      0.17/0.21    0.012   0.54(0.12;2.03)    0.1846      0.01/0.02 <br />  ADARB1       14      rs3788157        AA v AG/GG            0.63      1.16(1.00;1.34)       0.0204      0.65/0.62    0.65    1.03(0.79;1.36)    0.4080      0.67/0.66 <br />               15      rs414743         AA/AG v GG            0.47      0.83(0.72;0.96)       0.0053      0.43/0.48    0.31    1.14(0.86;1.52)    0.183       0.29/0.26 <br />               16      rs2838809        AA v AG/GG            0.009     0.46(0.19;1.08)       0.0297      0.005/0.01   0       0.81(0.36;1.81)    0.2959      0.028/0.034 <br />               17      rs2838810        AA/AG v GG            1         2.73(1.11;8.25)       0.0136      0.995/0.99   1       1.14(0.50;2.60)    0.3791      0.974/0.970 <br />               18      rs2838816        AA v AG/GG            0.009     0.48(0.18;1.04)       0.0309      0.005/0.01   0       0.81(0.36;1.79)    0.3032      0.029/0.034 <br />  <br />  Lists SNPs ADARB2 ADARB1 reach statistical significance NECS SICS attempted replicated JCS set. 7 columns <br />  report details SNPs described legend Table 3. Columns 8&#226;&#8364;&#8220;11 report results 14 18 SNPs Table 3 genotyped 470 oldest <br />  old 538 younger controls JCS. 3 SNPs reach statistical significance set (rows 1, 5 10) opposite effects compared  NECS SICS (row 1). did attempt merge results different populations substantial differences allele frequencies. <br />  doi:10.1371/journal.pone.0008210.t006 <br />  <br />  <br /> University, Tokyo, Japan (JCS). data analyzed anony-                          showed NECS Illumina controls mously. Control data Illumina iControlDB database                        comprised major clusters correspond northwest, <br /> anonymized.                                                                            northeast southwest Europeans, Illumina controls <br />                                                                                        sample subjects different levels admixture <br /> SNP Genotyping                                                                         clusters Figure S3. randomly <br />    NECS SICS samples, 1 ug genomic DNA                              sampled 1,538 subjects major clusters create analyzed Illumina 370 CNV chip (Illumina, San Diego,                            control set matched genetic background NECS <br /> CA) samples 93% rate used                       extreme old sample set suggested [49]. use analysis. AJCS JCS, genotyping originally                          procedure identify 81 female 16 male subjects added <br /> performed Affymetrix 6.0 chip 5.0 chips, respectively                     set SICS controls. random-selection procedure required rates 99% greater. Affymetrix Birdseed                        repeated twice lead results. <br /> algorithm Illumina Beadstudio used genotype calling. <br /> Non overlapping SNPs approximated SNPs                           Genetic Association Analysis (Pooled DNA Samples) <br /> substantial LD (D9.0.8) genotyped Sequenom (AJCS)                               statistical analysis pooling based genome-wide genotype BigDye Terminator cycle sequencing kit ABI Prism                            data described [27]. Briefly, method uses Bayesian <br /> 3730xl DNA analyzer (Applied Biosystems, CA, USA).                                 association tests score evidence allelic associations <br /> sequence data analyzed ABI PRISM SeqScape                                    centenarians controls. Prior distributions represent <br /> Software version 2.6 (Applied Biosystems).                                             prior knowledge expected number genes                                                                                        implicated trait correct multiple <br /> Creation Genetically Matched Control Set                                          comparisons. analysis uses linkage disequilibrium (LD) <br />    referent cohort sample NECS subjects constructed                      based filters retain associations supported clusters utilizing genotype data Illumina iControlDB database                          SNPs LD. principal components analysis used match cases controls genetic background. reduce chances stratifica-                       Genetic Association Analysis (Individual DNA Samples) <br /> tion, identified 2,077 Caucasian referent subjects                            genotype data 31 SNPs genes ADARB1 Illumina iControlDB, genotype Illumina arrays,                           114 SNPs ADARB2 individually analyzed using Bayesian <br /> known age enrollment 30 75 years, used                           logistic regression [32] fit dominant recessive models principal component analysis implemented program                            inheritance adjusted gender. marginal posterior distribu- <br /> EIGENSTRAT [48] examine structure referent                              tions ORs estimated using implementation group compared NECS SICS subjects. analysis                             Gibbs sampling WinBugs 1.4 [50], 2.5th 97.5th <br />  <br />  <br />        PLoS | www.plosone.org                                                  9                            December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                                                                                                                                                                                                                                                                                                                   RNA Editing Oldest Age <br />  <br />  <br />  <br />  <br />                                                                     referent alleles <br />                                                                                                                                                                                                                                                                                                                                                                       percentile used estimate 95% credible intervals (CI)                                                                                                                                                                                                                                                                                                                                                                       ORs. 50th percentile used estimate   <br />  <br />  <br />  <br />                                                                     Risk versus <br />  <br />  <br />  <br />  <br />                                                                                                                                CC/CG v GG <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                      CC/CG v GG <br />                                                                                                                                                                    CC v CG/GG <br />  <br />  <br />                                                                                                                                                                                                        AA v TT <br />                                                                                                                                                                                                                          CC/CT v TT <br />                                                                                                                                                  CC v CT/TT <br />                                                                                                                                                                                                                                                                                                                                                                       frequency 1 used estimate posterior probability <br />                                                                                                                                                                                                                                                                                                                                                                       p 1). Gibbs sampler run 10,000 <br />                                                                                                                                                                                                                                                                                                                                                                       iterations 10,000 simulated values used                                                                                                                                                                                                                                                                                                                                                                       estimate parameters. used prior distributions                                                                                                                                                                                                                                                                                                                                                                       regression coefficients logit function normal distributions <br />  <br />  <br />  <br />                                                                                                                                0.91/0.94 <br />                                                                                                                                                  0.09/0.06 <br />                                                                                                                                                                    0.08/0.05 <br />                                                                                                                                                                                      0.91/0.96 <br />                                                                                                                                                                                                        0.50/0.43 <br />                                                                                                                                                                                                                          0.89/0.93 <br />                                                                                                                                                                                                                                                                                                                                                                       mean 0 standard deviation 3.2 determine normal <br />  <br />                                                                                                                    p  <br />                                                                                                                                                                                                                                                                                                                                                                       prior distribution log  mean 0  association)                                                                                                                                                                                                                                                                                                                                                                       variance ranges 10 genetic effect 40                                                                              JPCS (432 oldest old, 346 controls) <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       gene6gender effect. set prior distributions                                                                                                                    Bayes sig <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       determined make analysis robust rare alleles (frequen- <br />                                                                                                                                0.0422 <br />                                                                                                                                                  0.0332 <br />                                                                                                                                                                    0.0234 <br />                                                                                                                                                                                      0.0031 <br />                                                                                                                                                                                                        0.0202 <br />                                                                                                                                                                                                                          0.0059 <br />                                                                                                                                                                                                                                                                                                                                                                       cy,0.10) searched largest variance allowed <br />                                                                                                                                                                                                                                                                                                                                                                       successful execution Gibbs sampler. prior distribu- <br />                                                                                                                                                                                                                                                                                                                                                                       tions bias analysis null hypothesis reduce false <br />                                                                                                                                                                                                                                                                                                                                                                       positive associations. <br />                                                                                                                                0.61(0.34;1.07) <br />                                                                                                                                                  1.70(0.97;3.05) <br />                                                                                                                                                                    1.84(1.01;3.58) <br />                                                                                                                                                                                      0.44(0.23;0.80) <br />                                                                                                                                                                                                        1.36(1.03;1.82) <br />                                                                                                                                                                                                                          0.54(0.30;0.86)                                                                                                                                 Bayes significance defined 1- p 1)                                                                                                                                                                                                                                                                                                                                                                       posterior estimate .1, 1-p 1)                                                                                                                                                                                                                                                                                                                                                                       posterior estimate ,1, association                                                                                                                                                                                                                                                                                                                                                                       deemed significant NECS, SICS, data aggregated <br />                                                                                                                     <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       studies, Bayes significance smaller                                                                                                                                                                                                                                                                                                                                                                       0.05. measure significance posterior probability                                                                                                                                                                                                                                                                                                                                                                       null hypothesis 1  OR$1) small values denotes <br />                                                                                                                                                                                                                          0.08/0.03 <br />                                                                                                                                                  1.00/0.58 <br />                                                                                                                                                                    0.91/0.22 <br />                                                                                                                                                                                      0.88/0.20 <br />                                                                                                                                                                                                        0.08/0.03 <br />                                                                                                                                0.63/0.3 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       strong evidence null hypothesis [32]. analysis <br />                                                                              D9/r2 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       identified 18 significant SNPs (Table 3), twice                                                                                                                                                                                                                                                                                                                                                                       number expected chance 145 independent tests                                                                                                                                                                                                                                                                                                                                                                       SNPs remained significant correcting threshold                                                                              Distance <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       number tests. Furthermore, probability 18 SNPs <br />                                                                                                                                                                                                                          25343 <br />                                                                                                                                                                                                        24675 <br />                                                                                                                                                  2224 <br />                                                                                                                                5232 <br />  <br />  <br />                                                                                                                                                                    8646 <br />                                                                                                                                                                                      2726 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       simultaneously significantly associated                                                                                                                                                                                                                                                                                                                                                                       null hypothesis association 0.0002, using binomial <br />                                                                                                                                                                                                                                            Additional SNPs genotyped JCS set corroborate associations NECS SICS subjects sets. <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       distribution n = 145, x = 18 p = 0.05. association                                                                                                                                                                                                                          45479813 <br />                                                                                                                                                                                                        45479145 <br />                                                                              position <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       significant aggregated NECS SICS data                                                                                                                                1346320 <br />                                                                                                                                                  1361386 <br />                                                                                                                                                                    1406472 <br />                                                                                                                                                                                      1453158 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       deemed replicated AJCS JCS studies                                                                                                                                                                                                                                                                                                                                                                       SNP significant (Bayes significance ,0.05)                                                                                                                                                                                                                                                                                                                                                                       genetic model consistent effects; SNP did                                                                                                                                                  rs10903426 <br />                                                                                                                                                                    rs17221652 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       reach statistical significance (Bayes significance $0.05),                                                                                                                                                                                                                          rs2838824 <br />                                                                                                                                rs2804099 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                      rs4543904 <br />                                                                                                                                                                                                        rs6518219 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       ORs different studies direction                                                                              SNP <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       data studies aggregated, association                                                                                                                                                                                                                                                                                                                                                                       significant. rationale second condition                                                                                                                                                                                                        0.005/0.01 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       AJCS JC smaller sample sizes,                                                                                                                                0.27/0.22 <br />                                                                                                                                                  0.12/0.10 <br />                                                                                                                                                                    0.15/0.13 <br />                                                                                                                                                                                      0.74/0.68 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       power compared NECS.  consistent effects                                                                                                                    p  <br />     Table 7. Replication JCS subject set using proxy SNPs. <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       increased significance aggregated data analyzed <br />                                                                                                                                                                                                                                                                                                                                                                       lack association replication study                                                                                                                    Bayes sig <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       lack power effects similar different studies.                                                                                                                                0.0003 <br />                                                                                                                                                  0.0211 <br />                                                                                                                                                                    0.0343 <br />                                                                                                                                                                                      0.0017 <br />                                                                                                                                                                                                        0.0309 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       strategy used increase power genetic association <br />                                                                                                                                                                                                                                                                                                                                                                       studies, example [51]. results Tables 4, 5, 6 <br />                                                                                                                                                                                                                                                                                                                                                                       7. <br />                                                                                                                                                                                                                                                                                                                                                                          conducted similar analysis stratified gender                                                                                                                                1.34(1.15;1.59) <br />                                                                                                                                                  1.24(1.01;1.54) <br />                                                                                                                                                                    1.22(0.98;1.48) <br />                                                                                                                                                                                      1.37(1.11;1.68) <br />                                                                                                                                                                                                        0.48(0.18;1.04) <br />                                                                              NECS+SICS <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       limited sample sizes did produce strongly significant results. <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       Linkage Disequilibrium (LD) Heatmaps <br />                                                                                                                     <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                          used HaploView 4.1 create LD heatmaps LD <br />                                                                                                                                                                                                                                                                                                                                                                       displays generated using D9 color scheme white <br />                                                                                                                                                                                                        45454470 <br />                                                                              position <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                            doi:10.1371/journal.pone.0008210.t007 <br />                                                                                                                                1341088 <br />                                                                                                                                                  1361610 <br />                                                                                                                                                                    1397826 <br />                                                                                                                                                                                      1450432 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       represents D9 = 0, red represents D9 = 1, different shades                                                                                                                                                                                                                                                                                                                                                                       red represent 0,D9,1 (Figures 1 4). <br />                                                                              Chr <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       Lifespan Measurements C. elegans <br />                                                                                                                                10 <br />                                                                                                                                                  10 <br />                                                                                                                                                                    10 <br />                                                                                                                                                                                      10 <br />                                                                                                                                                                                                        21 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                          synchronize worms lifespan, eggs isolated (N2, adr- <br />                                                                                                                                rs1007147 <br />  <br />  <br />                                                                                                                                                                    rs2387653 <br />                                                                                                                                                                                      rs2805535 <br />                                                                                                                                                                                                        rs2838816 <br />                                                                                                                                                  rs884949 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       1, adr-2, adr-1;adr-2, rde-1, rde-4, adr-1;adr-2;rde-1) synchronized <br />                                                                                                                                                                                                                                                                                                                                                                       hatching overnight absence food 20C. Synchronized <br />                                                                              SNP <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       L1 larvae counted plated (10 worms/plate, n = 60)                                                                                                                                                                                                                                                                                                                                                                       Escherichia coli bacterial lawns (OP50) NGM media                                                                              Row <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       allowed develop L4-stage larvae 20C. 5-fluorodeoxyur- <br />                                                                                                                                                                                                        18 <br />                                                                                                                                2 <br />                                                                                                                                                  4 <br />                                                                                                                                                                    6 <br />                                                                                                                                                                                      7 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                                                                                       idine (FudR) solution added final concentration 0.1mg/ <br />  <br />  <br /> PLoS | www.plosone.org                                                                                                                                                                                                                                                                                                                                       10                         December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                          RNA Editing Oldest Age <br />  <br />  <br />  <br />  <br /> Figure 3. Posterior densities ORs. Posterior densities ORs 3 SNPs ADARB1 rare alleles moderate effects data <br /> aggregated NECS, SICS JCS. Significant associations results posterior densities overlapping 1 definite evidence 1 1, densities heavy tails provide definite evidence null hypothesis association. <br /> doi:10.1371/journal.pone.0008210.g003 <br />  <br /> ml prevent reproduction. Worms kept 20C lifespan               behavior, consistent previous reports adr mutant strains <br /> monitored counting alternate days. Lifespan defined              [36]. did observe altered chemotaxis routine passage day adulthood (adult lifespan = 0) death. Aside          worms maintain stocks, previously noted [36]. reduced lifespan, worms appeared normal size general               noted reduced progeny viability (data shown).   <br />  <br />  <br />  <br /> Figure 4. Pattern LD SNP ADARB2 (chromosome 10) associated exceptional longevity. plots <br /> display pattern LD captured SNPs associated exceptional longevity ADARB2 (chromosome 10) NECS, SICS, AJCS JCS <br /> data. intensity red cells represents strength LD measured D9. LD pattern NECS, SICS AJCS subjects similar differ substantially pattern LD JCS subjects SNPs monomorphic (rs884949 rs2387653). <br /> Highlighted red SNPs replicate results AJCS JCS subjects. <br /> doi:10.1371/journal.pone.0008210.g004 <br />  <br />  <br />        PLoS | www.plosone.org                                        11                        December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                              RNA Editing Oldest Age <br />  <br />  <br />  <br />  <br /> Figure 5. Age related trend allele frequencies. barplots age related trend allele frequencies SNPs rs17294019 <br /> (ADARB2, SNP # 98 Table 1) rs3788157 (ADARB1, SNP # 135 Table 1) NECS (n = 1,023). frequencies common allele SNPs stratified age groups 90&#226;&#8364;&#8220;99; 100&#226;&#8364;&#8220;105, 106 higher. Trends allele frequencies increasing age groups consistent strong correlation genotype phenotype results substantial enrichment protective alleles older subjects. <br /> doi:10.1371/journal.pone.0008210.g005 <br />  unlikely influenced lifespan measurements,                RNAi Lifespan Measurement adult worms sterile using FudR                         Eggs isolated gravid worms synchronized transferred course lifespan assay.                            hatching overnight absence food. synchronized L1 <br />  <br />  <br />  <br />  <br /> Figure 6. ADAR mediated decline lifespan, daf-2 influence, rde-1 rescue.  Lifespan using mutant strains adr-1;adr-2 context dsRNA mediated gene inactivation daf-2. Synchronized worms larval stage 4 (L4) sterilized FudR allowed feed bacterial lawns contained dsRNA daf-2. Note: adr-1; adr-2 double mutant (red solid), adr-1; adr-2 double mutant dsRNA daf-2 (red <br /> hatched), N2 wild type (blue solid), N2 dsRNA daf-2 (blue hatched). Note decline lifespan adr-1; adr-2 compared N2 wildtype. note increases lifespan N2 adr-1; adr-2 presence dsRNA daf-2. 50% survival time adr-1; adr-2 mutant <br /> animals 10 days (95% limits 9 12 days) compared 20 days (95% limits 18 20 days) N2 wild-type control worms. RNAi daf-2 <br /> increases lifespan 34 days (95% limits 32 40 days), compared 20 days wild type (N2 worms fed vector (RNAi)). daf-2 gene <br /> inactivation, background adr-1 adr-2 null mutations restored lifespan 18 days (95% limits 16 20 days), compared 10 <br /> days adr-1;adr-2 double mutant strain. b) Lifespan using mutant strains adr-1;adr-2 (solid red), N2 wildtype (solid blue), rde-1 (grey <br /> hatched), adr-1; adr-2; rde-1 (grey solid) demonstrate declines lifespan using mutant strains rescue lifespan RNAi defective (rde-1) <br /> background. adr-1; adr-2 mutant half long lived wild-type (median survival time 9 days adr-1;adr-2 strain (95% limits 9 11 days), median survival time 21 days (95% limits 18 21 days), N2 wild-type worms. survival distribution triple mutant adr- <br /> 1;adr-2; rde-1 median lifespan 21 days (95% limits 18 21 days), significantly different adr-1;adr-2, median lifespan 9 days <br /> (95% limits 9 11 days). lifespan rde-1 modestly reduced compared wild-type N2, reported previously29. Inset boxes <br /> displays 50% survival (days) condition demonstrates daf-2 gene inactivation increases lifespan, wild type adr-1;adr-2 <br /> mutant strains   RNAi knockout (rde-1) restores lifespan. <br /> doi:10.1371/journal.pone.0008210.g006 <br />  <br />  <br />        PLoS | www.plosone.org                                          12                         December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                                               RNA Editing Oldest Age <br />  <br />  <br /> larvae placed OP50-containing agar plates                              Figure S3 Population structure NECS centenarians allowed develop L4-stage larvae 20C. L4-stage larvae                       controls, SICS centenarians controls, Illumina controls. washed thoroughly, placed Escherichia coli                           Population structure NECS centenarians (blue) controls <br /> HT115 RNAi vector Escherichia coli HT115                                  (red), SICS centenarians (green) controls (orange), Illumina <br /> expressing double-stranded RNA (dsRNA) daf-2. Briefly,                              controls (grey). scatter plot shows principal <br /> dsRNA -expressing bacteria grown overnight LB                              components estimated using genotype data 50 ug/ml ampicillin seeded RNAi NGM plates                                300K SNPs NECS, SICS Illumina subjects using containing 5 mM isopropylthiogalactoside (IPTG). RNAi                               program Eigenstrat.  left right: (Blue) scatter <br /> bacteria induced overnight room temperature dsRNA                           plot principal components centenarians expression. 30 synchronized L4-stage animals added                           NECS. principal components (PC1 displayed x-axis allowed develop adults, followed                          PC2 y-axis) identify 3 major clusters based addition FudR. Worms kept 20C, lifespan                        ancestry NECS centenarians labeled NW <br /> monitored. Worms feeding bacteria carrying vector                          Europeans (PC1,0.005 20.0125,PC2,0.0125), Ashkenazi used negative control. Log-rank test R package                         Jews (PC1.0.005 PC2,20.0125) SW Europeans/ <br /> survival used statistical analysis.                                         Italians (PC1.0.005 PC2.0.0125). thresholds                                                                                         principal components identified splitting components <br /> Supporting Information                                                                  using mixture models. (Green) scatter plot principal <br /> Figure S1    Phylogenetic clustering alignment ADARs                             components centenarians SICS. agreement form multiple species. Phylogenetic clustering alignment                         analysis NECS subjects, centenarians SICS SW <br /> ADARs form multiple species, including Human, chimp, bull, cat,                         European genetic background. (Red) scatter plot rat, chicken, wolf nematode (C. elegans). Sequences                            principal components controls NECS display <br /> aligned using neighbor-joining algorithm Clustal X,                         approximately population substructure centenarians; <br /> gap-stripped corrections multiple substitutions,                           (Grey) scatter plot principal components bootstrap analyzed 1,000 bootstrap resamplings. Phylograms                         Illumina controls. plots controls generated NJ-plot. tree unrooted                               population substructure similar NECS cases controls <br /> generated using Neighbor Joining algorithm implemented                             larger level admixture European <br /> Clustal X. Note bootstrap values defining main ADAR                           subgroups. (Orange) scatter plot principal <br /> branches.                                                                               components controls SICS exhibit SW  doi:10.1371/journal.pone.0008210.s001 (0.07 MB TIF)                           European genetic background SICS centenarians. Note                                                                                         plot PC1 PC2 NECS controls (red) repeated twice Figure S2 C. elegans lifespan results using individual gene <br />                                                                                         facilitate comparisons NECS subjects mutant strains. C. elegans lifespan results using individual gene <br />                                                                                         NECS Illumina controls. <br /> mutant strains, indicated. Eggs isolated gravid worms <br />                                                                                          doi:10.1371/journal.pone.0008210.s003 (0.12 MB TIF) synchronized hatching overnight absence food. synchronized L1 larvae placed OP50- <br /> containing agar plates allowed develop L4-stage larvae                        Acknowledgments 20C. L4-stage larvae washed thoroughly, placed                          grateful subjects families centenarian Escherichia coli expressing double-stranded RNA (dsRNA)                          studies. thank Elixir Pharmaceuticals Fondazione Longevita daf-2. Briefly, dsRNA -expressing bacteria grown overnight                         DNA referent cohort subjects residing Cilento, Italy LB 50 ug/ml ampicillin seeded RNAi NGM                            Illumina access control subject genotype database, Ms Yukiko <br /> plates containing 5 mM isopropylthiogalactoside (IPTG).                             Abe, Ms Sanae Fujimaki (Division geriatric medicine, Department <br /> RNAi daf-2 bacteria induced overnight room temperature                          Internal medicine, Keio University School medicine)                                                                                         technical assistance excellent secretarial work. daf-2 dsRNA mediated knockdown expression. 30 <br /> synchronized L4-stage animals added allowed develop adults, followed addition FudR.                         Author Contributions <br /> Worms kept 20C, lifespan monitored.                               Conceived designed experiments: PS MM MHS GR CB TP. <br /> Worms feeding bacteria carrying vector used                        Performed experiments: PS MM TK MCW EM MM SEJF YA CVA negative control. Animals scored 1 2 days                               AK GA CB. Analyzed data: PS MM NS SHH TP. <br /> subsequently scored dead longer responded                           Contributed reagents/materials/analysis tools: PS MM AAP TK SLA gentle prodding.                                                                     SHH YA AB NB DT AR MS TA YG MHS NH GA GR CB TP. Wrote <br />                                                                                         paper: PS MM NS MHS GR CB TP.  doi:10.1371/journal.pone.0008210.s002 (0.05 MB TIF) <br />  <br />  <br /> References <br /> 1. Christensen K, Johnson TE, Vaupel JW (2006) quest genetic                     6. Perls TT, Wilmoth J, Levenson R, Drinkwater M, Cohen M, et al. (2002) Life- <br />    determinants human longevity: challenges insights. Nat Rev Genet 7:               long sustained mortality advantage siblings centenarians. Proc Natl Acad <br />    436&#226;&#8364;&#8220;448.                                                                                 Sci USA 99: 8442&#226;&#8364;&#8220;8447. <br /> 2. Gudmundsson H, Gudbjartsson DF, Frigge M, Gulcher JR, Stefansson K (2000)             7. Schoenmaker M, Craen AJ, Meijer PH, Beekman M, Blauw GJ, et al. <br />    Inheritance human longevity Iceland. Eur J Hum Genet 8: 743&#226;&#8364;&#8220;749.                   (2006) Evidence genetic enrichment exceptional survival using family <br /> 3. Hjelmborg JV, Iachine  Skytthe  Vaupel JW, McGue M, et al. (2006)                    approach: Leiden Longevity Study. European Journal Human Genetics <br />    Genetic influence human lifespan longevity. Hum Genet 119: 312&#226;&#8364;&#8220;                   14: 79&#226;&#8364;&#8220;84. <br />    321.                                                                                  8. Terry DF, Wilcox MA, McCormick MA, Pennington JY, Schoenhofen EA, <br /> 4. Kerber RA, O&#226;&#8364;&#8482;Brien E, Smith KR, Cawthon RM (2001) Familial excess                        et al. (2004) Lower cause, cardiovascular, cancer mortality    longevity Utah genealogies. J Gerontol Biol Sci Med Sci 56: B130&#226;&#8364;&#8220;139.               centenarians&#226;&#8364;&#8482; offspring. J Geriatr Soc 52: 2074&#226;&#8364;&#8220;2076. <br /> 5. Perls T, Shea-Drinkwater M, Bowen-Flynn J, Ridge SB, Kang S, et al. (2000)            9. Christensen K, McGue M, Petersen  Jeune B, Vaupel JW (2008) Exceptional <br />    Exceptional familial clustering extreme longevity humans. J Geriatr            longevity does result excessive levels disability. Proc Natl Acad Sci U S    Soc 48: 1483&#226;&#8364;&#8220;1485.                                                                       105: 13274&#226;&#8364;&#8220;13279. <br />  <br />  <br />  <br />       PLoS | www.plosone.org                                                   13                              December 2009 | Volume 4 | Issue 12 | e8210 <br />                                                                                                                                                    RNA Editing Oldest Age <br />  <br />  <br /> 10. Hitt R, Young-Xu Y, Silver M, Perls T (1999) Centenarians: older              31. Maas S, Kawahara Y, Tamburro KM, Nishikura K (2006) RNA editing <br />     healthier  Lancet 354: 652.                                                 human disease. RNA Biol 3: 1&#226;&#8364;&#8220;9. <br /> 11. Terry DF, Sebastiani P, Andersen SL, Perls TT (2008) Disentangling roles           32. Balding DJ (2006) tutorial statistical methods population association <br />     disability morbidity survival exceptional old age. Arch Intern Med 168:             studies. Nat Rev Genet 7: 781&#226;&#8364;&#8220;791. <br />     277&#226;&#8364;&#8220;283.                                                                                  33. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, et al. (1994) <br /> 12. Atzmon G, Schechter C, Greiner W, Davidson D, Rennert G, et al. (2004)                        Genetic associations human longevity APOE ACE loci. Nat <br />     Clinical phenotype families longevity. J Geriatr Soc 52: 274&#226;&#8364;&#8220;277.                  Genet 6: 29&#226;&#8364;&#8220;32. <br /> 13. Evert J, Lawler E, Bogan H, Perls T (2003) Morbidity profiles centenarians:            34. Vaupel JW, Carey JR, Christensen K, Johnson TE, Yashin AI, et al. (1998) <br />     survivors, delayers, escapers. J Gerontol Biol Sci Med Sci 58: 232&#226;&#8364;&#8220;237.                 Biodemographic trajectories longevity. Science 280: 855&#226;&#8364;&#8220;860. <br /> 14. Schoenhofen EA, Wyszynski DF, Andersen S, Pennington J, Young R, et al.                   35. Morse DP, Aruscavage PJ, Bass BL (2002) RNA hairpins noncoding regions <br />     (2006) Characteristics 32 supercentenarians. J Geriatr Soc 54:                          human brain Caenorhabditis elegans mRNA edited adenosine <br />     1237&#226;&#8364;&#8220;1240.                                                                                    deaminases act RNA. Proc Natl Acad Sci U S 99: 7906&#226;&#8364;&#8220;7911. <br /> 15. Finch CE, Tanzi (1997) Genetics aging. Science 278: 407&#226;&#8364;&#8220;411.                        36. Tonkin LA, Saccomanno L, Morse DP, Brodigan T, Krause M, et al. (2002) <br /> 16. Salvioli S, Olivieri F, Marchegiani F, Cardelli M, Santoro  et al. (2006) Genes,            RNA editing ADARs important normal behavior Caenorhabditis <br />     ageing longevity humans: problems, advantages perspectives. Free                   elegans. EMBO J 21: 6025&#226;&#8364;&#8220;6035. <br />     Radic Res 40: 1303&#226;&#8364;&#8220;1323.                                                                  37. Keegan LP, Brindle J, Gallo  Leroy  Reenan RA, et al. (2005) Tuning 17. Sorkin J, Post W, Pollin TI, O&#226;&#8364;&#8482;Connell JR, Mitchell BD, et al. (2005) Exploring               RNA editing ADAR required Drosophila. EMBO J 24: 2183&#226;&#8364;&#8220;2193. <br />     genetics longevity Old Order Amish. Mech Ageing Dev 126:                    38. Kenyon C, Chang J, Gensch E, Rudner  Tabtiang R (1993) C. elegans <br />     347&#226;&#8364;&#8220;350.                                                                                      mutant lives twice long wild type. Nature 366: 461&#226;&#8364;&#8220;464. <br /> 18. Perls T (2001) Genetic phenotypic markers centenarians.                         39. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, et al. (2001) <br />     J Gerontol Biol Sci Med Sci 56: M67&#226;&#8364;&#8220;70.                                                     Extension life-span loss CHICO, Drosophila insulin receptor substrate <br /> 19. Perls T, Kunkel L, Puca (2002) genetics aging. Curr Opin Genet Dev                   protein. Science 292: 104&#226;&#8364;&#8220;106. <br />     12: 362&#226;&#8364;&#8220;369. <br />                                                                                               40. Tatar M, Kopelman  Epstein D, Tu MP, Yin CM, et al. (2001) mutant <br /> 20. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, et al. (2003) <br />                                                                                                   Drosophila insulin receptor homolog extends life-span impairs <br />     Unique lipoprotein phenotype genotype associated exceptional <br />                                                                                                   neuroendocrine function. Science 292: 107&#226;&#8364;&#8220;110. <br />     longevity. JAMA 290: 2030&#226;&#8364;&#8220;2040. <br />                                                                                               41. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen  et al. (2003) IGF-1 <br /> 21. Atzmon G, Rincon M, Schechter CB, Shuldiner AR, Lipton RB, et al. (2006) <br />                                                                                                   receptor regulates lifespan resistance oxidative stress mice. Nature 421: <br />     Lipoprotein genotype conserved pathway exceptional longevity                                                                                                   182&#226;&#8364;&#8220;187. <br />     humans. PLoS Biol 4: e113. <br />                                                                                               42. Suh Y, Atzmon G, Cho M-O, Hwang D, Bingrong L, et al. (2008) Functionally <br /> 22. Atzmon G, Pollin TI, Crandall J, Tanner K, Schechter CB, et al. (2008) <br />                                                                                                   significant insulin-like growth factor 1 receptor mutations centenarians. Proc <br />     Adiponectin levels genotype: potential regulator life span humans. <br />     J Gerontol Biol Sci Med Sci 63: 447&#226;&#8364;&#8220;453.                                                    Natl Acad Sci U S 105: 3438&#226;&#8364;&#8220;3442. <br /> 23. Willcox BJ, Donlon TA, Q, Chen R, Grove JS, et al. (2008) FOXO3A                       43. Lee SS, Kennedy S, Tolonen AC, Ruvkun G (2003) DAF-16 target genes     genotype strongly associated human longevity. Proc Natl Acad Sci U S                control C. elegans life-span metabolism. Science 300: 644&#226;&#8364;&#8220;647. <br />     105: 13987&#226;&#8364;&#8220;13992.                                                                         44. Knight S, Bass B (2002) role RNA editing ADARs RNAi. Mol Cell <br /> 24. Flachsbart F, Caliebe  Kleindorp R, Blanche H, von Eller-Eberstein H, et al.                Biol 10: 809&#226;&#8364;&#8220;817. <br />     (2009) Association FOXO3A variation human longevity confirmed                  45. Tonkin LA, Bass BL (2003) Mutations RNAi rescue aberrant chemotaxis     German centenarians. Proc Natl Acad Sci U S 106: 2700&#226;&#8364;&#8220;2705.                                 ADAR mutants. Science 302: 1725. <br /> 25. Vijg J, Campisi J (2008) Puzzles, promises cure ageing. Nature 454:             46. Lund J, Tedesco P, Duke K, Wang J, Kim SK, et al. (2002) Transcriptional <br />     1065&#226;&#8364;&#8220;1071.                                                                                    profile aging C. elegans. Curr Biol 12: 1566&#226;&#8364;&#8220;1573. <br /> 26. Kojima T, Kamei H, Aizu T, Arai Y, Takayama M, et al. (2004) Association                  47. Wang D, Ruvkun G (2004) insulin pathway regulates RNAi C. elegans. <br />     analysis longevity Japanese population polymorphic variants                Cold Spring Harbor Symposium Quantitative Biology, 69th edition 69: <br />     genes involved insulin insulin-like growth factor 1 signaling pathways.             429&#226;&#8364;&#8220;433. <br />     Exp Gerontol 39: 1595&#226;&#8364;&#8220;1598.                                                               48. Price AL, Patterson NJ, Plenge RM, Weinblatt  Shadick NA, et al. (2006) <br /> 27. Sebastiani P, Zhao  Abad-Grau MM, Riva  Hartley SW, et al. (2008)                       Principal components analysis corrects stratification genome-wide <br />     hierarchical modular approach discovery robust associations                  association studies. Nat Genet 38: 904&#226;&#8364;&#8220;909. <br />     genome-wide association studies pooled DNA samples. BMC Genetics 9: 6.               49. Hinds DA, Stokowski RP, Patil N, Konvicka K, Kershenobich D, et al. (2004) <br /> 28. Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated s                     Matching strategies genetic association studies structured populations. <br />     syndrome USA 1983 1997: population-based study. Lancet 359:                  J Hum Genet 74: 317&#226;&#8364;&#8220;325. <br />     1019&#226;&#8364;&#8220;1025.                                                                                50. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR (1999) Methods health <br /> 29. Yang JH, Luo X, Nie Y, Su Y, Zhao Q, et al. (2003) Widespread inosine-                        service research. introduction bayesian methods health technology <br />     containing mRNA lymphocytes regulated ADAR1 response                              assessment. BMJ 319: 508&#226;&#8364;&#8220;512. <br />     inflammation. Immunology 109: 15&#226;&#8364;&#8220;23.                                                      51. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P <br /> </body></html>